FOLH1 and neoplasm: In conclusion, the results of this exploratory analysis indicate that the baseline68Ga-PSMA-11 whole-body tumor mean standardized uptake value(SUVmean) was the best predictor of 177Lu-PSMA-617efficacy in participants with prostate-specific membrane antigen–positivemetastatic castration-resistant prostate cancer in the VISION trial who wereselected for the study based on visual read rules.